Myeong-Jae Park
Corporate Officer/Principal presso CHA University
Provenienza dei contatti di primo grado di Myeong-Jae Park
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
CHA University
5
| College/University | Other Consumer Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Myeong-Jae Park tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NEXEN TIRE CORPORATION | Automotive Aftermarket | Director/Board Member | |
| PAPERCOREA INC. | Pulp & Paper | Director/Board Member | |
| VT CO., LTD. | Household/Personal Care | Director/Board Member | |
| HYUNDAI BIOLAND CO.,LTD. | Chemicals: Major Diversified | Director/Board Member | |
| Yonsei University | College/University | Doctorate Degree | |
| Konkuk University | College/University | Doctorate Degree | |
| University of Tsukuba | College/University | Doctorate Degree | |
| CHABIOTECH CO.,LTD. | Electronic Components | President | |
| THERAGEN ETEX CO.,LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CHA Health Systems, Inc.
 CHA Health Systems, Inc. Medical/Nursing ServicesHealth Services Part of Cha Biotech Co., Ltd., CHA Health Systems, Inc. is a leader in the biotechnology industry. The company is based in Los Angeles, CA. CHA Health Systems delivers world-class care in all facets of medicine, with a focus on fertility and cutting-edge therapies using cord blood stem cells and immune cells. The company is known for their research and clinical work in these fields. CHA Health Systems consists of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. The CEO of the company is Yong-Seok Kim. | Medical/Nursing Services | Chief Executive Officer | |
Stem Cell & Regenerative Medicine International, Inc.
 Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Stem Cell & Regenerative Medicine International, Inc. engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company is headquartered in Marborough, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| MEDPACTO, INC. | Pharmaceuticals: Major | Founder | |
| CARELABS CO.,LTD | Packaged Software | Director/Board Member | |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Biotechnology | Founder |
Statistiche
Distribuzione geografica
| Corea del Sud | 11 |
| Stati Uniti | 4 |
| Giappone | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Process Industries | 3 |
| Consumer Durables | 2 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 12 |
| Independent Dir/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Doctorate Degree | 3 |
| Chief Executive Officer | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Hyung-Min Chung | 5 |
| Seong-Jin Kim | 5 |
| Tae-Joon Jeon | 5 |
| Kwang-Hyun Baek | 2 |
| Kwang-Hyun Koh | 2 |
- Borsa valori
- Insiders
- Myeong-Jae Park
- Connessioni Società
